Outpatient intensive induction chemotherapy for acute myeloid leukemia and high-risk myelodysplastic syndrome

To improve patient quality of life and reduce health care costs, many conditions formerly thought to require inpatient care are now treated in the outpatient setting. Outpatient induction chemotherapy for acute myeloid leukemia (AML) may confer similar benefits. This possibility prompted a pilot stu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood Adv
Hauptverfasser: Mabrey, Frances Linzee, Gardner, Kelda M., Shannon Dorcy, Kathleen, Perdue, Andrea, Smith, Heather A., Davis, Alicyn M., Hammer, Cody, Rizzuto, Donelle, Jones, Sunny, Quach, Kim, Scott, Bart L., Hendrie, Paul C., Percival, Mary-Elizabeth M., Walter, Roland B., Appelbaum, Frederick R., Estey, Elihu H., Becker, Pamela S.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Hematology 2020
Schlagworte:
Clinical Trials and Observations
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7042997/
https://ncbi.nlm.nih.gov/pubmed/32074276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000707
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge